The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA to Convene Pharmacy Compounding Advisory Committee in July The Blacklisting of Peptides Alternative Treatments: Identifying Options After FDA Reclassification of Specific Peptides Bergen Total Health BREAKING NEWS: HHS Secretary Kennedy just announced that the FDA is taking a step toward restoring science based access by removing 12 peptides from Category 2 and advancing them for formal review.